Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Centene Corp.

Start price
Target price
Perf. (%)
€50.50
22.01.21
-
22.01.22
9.90%
30.03.21

buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€219.23
21.01.21
€215.00
2.46%
15.02.21

Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
Stryker Corp.

Start price
Target price
Perf. (%)
€200.15
14.01.21
-
14.01.22
18.13%
15.01.22

buy
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€420.10
10.01.21
-
10.01.22
29.87%
02.11.21

buy
Hologic Inc.

Start price
Target price
Perf. (%)
€60.00
31.12.20
€78.00
31.12.21
10.17%
01.01.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Boston Scientific

Start price
Target price
Perf. (%)
€28.59
25.12.20
-
25.12.21
30.56%
26.12.21

buy
Align Technology

Start price
Target price
Perf. (%)
€434.90
24.12.20
-
24.12.21
0.72%
29.03.21

buy
Illumina Inc.

Start price
Target price
Perf. (%)
€295.30
21.12.20
-
21.12.21
14.26%
22.12.21

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€273.65
16.12.20
-
16.12.21
-0.75%
23.02.21

Boston Scientific

Start price
Target price
Perf. (%)
€28.14
01.12.20
€25.00
01.12.21
20.06%
02.12.21

buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€94.70
24.11.20
€100.00
1.43%
25.11.20

buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€92.45
24.11.20
€100.00
2.43%
24.11.20

buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€71.27
18.11.20
-
18.11.21
0.41%
09.02.21

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€296.90
12.11.20
€400.00
12.11.21
35.67%
13.11.21

Abiomed Inc.

Start price
Target price
Perf. (%)
€230.30
07.11.20
-
07.11.21
36.91%
08.11.21

buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€66.91
07.11.20
-
07.11.21
53.19%
08.11.21

buy
Humana Inc.

Start price
Target price
Perf. (%)
€362.00
04.11.20
-
04.11.21
7.98%
05.11.21

buy
Humana Inc.

Start price
Target price
Perf. (%)
€364.00
03.11.20
-
04.11.21
-6.04%
14.01.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€89.88
30.10.20
-
04.11.21
7.35%
03.01.21

Higher EBIT margin than peer group
Market Leader or Top 3
Known brand
Future proof or reliable business model
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€61.08
30.10.20
-
04.11.21
48.40%
15.07.21

Abiomed Inc.

Start price
Target price
Perf. (%)
€214.60
30.10.20
-
04.11.21
22.55%
15.07.21

UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€255.80
29.10.20
-
04.11.21
36.92%
15.07.21

Abiomed Inc.

Start price
Target price
Perf. (%)
€216.75
29.10.20
-
30.10.20
-0.99%
30.10.20

buy
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€371.00
29.10.20
-
04.11.21
8.65%
30.12.20

EBIT growth >5% per year expected
Very low/no dividend yield expected